The global imaging agents market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing number of patients with chronic diseases and rising demand for minimally invasive procedures. Oncology segment accounted for the largest share in the global imaging agents market in 2018, followed by cardiology, gastrointestinal disorders, neurology disorders and others (e.g., dermatology). Oncology segment is expected to continue its dominance throughout the forecast period due to increasing incidence rates of cancer globally and growing adoption of oncological treatments such as chemotherapy and radiotherapy. Cardiology segment is projected to grow at a CAGR of 6% during the forecast period due to increasing prevalence rates of cardiovascular diseases globally and growing adoption rate for minimally invasive procedures such as angioplasty or stenting procedures which require use of contrast agents. Gastrointestinal disorders are projected to grow at a CAGR higher than 7% during the forecast period due to rising incidence rates among people aged 65 years or older who are more susceptible towards gastrointestinal problems such as ulcers or colitis which require use of contrast agents for diagnosis purposes.
Some Of The Growth Factors Of This Market:
- The Imaging Agents market is driven by the increasing prevalence of chronic diseases, such as cancer and diabetes, which are leading to an increase in the number of imaging procedures.
- The Imaging Agents market is also driven by the increasing demand for minimally invasive procedures and diagnostic imaging devices.
- Increasing healthcare expenditure in emerging economies such as China and India will drive growth in the Imaging Agents market.
- Technological advancements in medical imaging equipment will also drive growth.
Industry Growth Insights published a new data on “Imaging Agents Market”. The research report is titled “Imaging Agents Market research by Types (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders), By Applications (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others), By Players/Companies Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Imaging Agents Market Research Report
By Type
Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders
By Application
Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others
By Companies
Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Imaging Agents Market Report Segments:
The global Imaging Agents market is segmented on the basis of:
Types
Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Healthcare Pharmaceuticals
- Bracco Diagnostics
- Daiichi Sankyo
- Eisai
- Eli Lilly and Company
- EUSA Pharma
- GE Healthcare
- Guerbet Group
- Lantheus Medical Imaging
- Mallinckrodt Pharmaceuticals
- Shenzhen Xingjingwei
- Beijing Chemical Reagent Research Institute
- Lanxing Chemial Materials
- Baoding Lucky Chemical
Highlights of The Imaging Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oncology
- Cardiology
- Gastrointestinal Disorders
- Neurology Disorders
- By Application:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic & imaging centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Imaging Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Imaging agents are chemicals that can be used to create images of the body. These images may be used for medical purposes, such as diagnosing diseases or injuries, or for cosmetic purposes, such as improving the appearance of skin.
Some of the major companies in the imaging agents market are Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical.
The imaging agents market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Imaging Agents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Imaging Agents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Imaging Agents Market - Supply Chain
4.5. Global Imaging Agents Market Forecast
4.5.1. Imaging Agents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Imaging Agents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Imaging Agents Market Absolute $ Opportunity
5. Global Imaging Agents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Imaging Agents Market Size and Volume Forecast by Type
5.3.1. Oncology
5.3.2. Cardiology
5.3.3. Gastrointestinal Disorders
5.3.4. Neurology Disorders
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Imaging Agents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Imaging Agents Market Size and Volume Forecast by Application
6.3.1. Hospitals & Clinics
6.3.2. Ambulatory Surgical Centers
6.3.3. Diagnostic & imaging centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Imaging Agents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Imaging Agents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Imaging Agents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Imaging Agents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Imaging Agents Demand Share Forecast, 2019-2026
9. North America Imaging Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Imaging Agents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Imaging Agents Market Size and Volume Forecast by Application
9.4.1. Hospitals & Clinics
9.4.2. Ambulatory Surgical Centers
9.4.3. Diagnostic & imaging centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Imaging Agents Market Size and Volume Forecast by Type
9.7.1. Oncology
9.7.2. Cardiology
9.7.3. Gastrointestinal Disorders
9.7.4. Neurology Disorders
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Imaging Agents Demand Share Forecast, 2019-2026
10. Latin America Imaging Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Imaging Agents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Imaging Agents Market Size and Volume Forecast by Application
10.4.1. Hospitals & Clinics
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic & imaging centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Imaging Agents Market Size and Volume Forecast by Type
10.7.1. Oncology
10.7.2. Cardiology
10.7.3. Gastrointestinal Disorders
10.7.4. Neurology Disorders
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Imaging Agents Demand Share Forecast, 2019-2026
11. Europe Imaging Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Imaging Agents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Imaging Agents Market Size and Volume Forecast by Application
11.4.1. Hospitals & Clinics
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic & imaging centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Imaging Agents Market Size and Volume Forecast by Type
11.7.1. Oncology
11.7.2. Cardiology
11.7.3. Gastrointestinal Disorders
11.7.4. Neurology Disorders
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Imaging Agents Demand Share, 2019-2026
12. Asia Pacific Imaging Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Imaging Agents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Imaging Agents Market Size and Volume Forecast by Application
12.4.1. Hospitals & Clinics
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic & imaging centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Imaging Agents Market Size and Volume Forecast by Type
12.7.1. Oncology
12.7.2. Cardiology
12.7.3. Gastrointestinal Disorders
12.7.4. Neurology Disorders
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Imaging Agents Demand Share, 2019-2026
13. Middle East & Africa Imaging Agents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Application
13.4.1. Hospitals & Clinics
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic & imaging centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Type
13.7.1. Oncology
13.7.2. Cardiology
13.7.3. Gastrointestinal Disorders
13.7.4. Neurology Disorders
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Imaging Agents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Imaging Agents Market: Market Share Analysis
14.2. Imaging Agents Distributors and Customers
14.3. Imaging Agents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer Healthcare Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bracco Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daiichi Sankyo
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eisai
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly and Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. EUSA Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GE Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Guerbet Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lantheus Medical Imaging
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mallinckrodt Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shenzhen Xingjingwei
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Beijing Chemical Reagent Research Institute
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Lanxing Chemial Materials
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Baoding Lucky Chemical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook